Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $115.56 billion. The enterprise value is $105.39 billion.
| Market Cap | 115.56B |
| Enterprise Value | 105.39B |
Important Dates
The last earnings date was Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 253.72 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 253.72M |
| Shares Outstanding | 253.72M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.50% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 95.09% |
| Float | 252.93M |
Valuation Ratios
The trailing PE ratio is 32.02 and the forward PE ratio is 22.77. VRTX's PEG ratio is 0.08.
| PE Ratio | 32.02 |
| Forward PE | 22.77 |
| PS Ratio | 9.97 |
| Forward PS | 8.85 |
| PB Ratio | 6.68 |
| P/TBV Ratio | 7.31 |
| P/FCF Ratio | 34.63 |
| P/OCF Ratio | 31.08 |
| PEG Ratio | 0.08 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.37, with an EV/FCF ratio of 31.58.
| EV / Earnings | 28.68 |
| EV / Sales | 8.99 |
| EV / EBITDA | 22.37 |
| EV / EBIT | 23.23 |
| EV / FCF | 31.58 |
Financial Position
The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.36 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.55 |
| Interest Coverage | 354.41 |
Financial Efficiency
Return on equity (ROE) is 22.31% and return on invested capital (ROIC) is 15.51%.
| Return on Equity (ROE) | 22.31% |
| Return on Assets (ROA) | 12.04% |
| Return on Invested Capital (ROIC) | 15.51% |
| Return on Capital Employed (ROCE) | 22.25% |
| Revenue Per Employee | $1.92M |
| Profits Per Employee | $602,475 |
| Employee Count | 6,100 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 4.10 |
Taxes
In the past 12 months, VRTX has paid $773.60 million in taxes.
| Income Tax | 773.60M |
| Effective Tax Rate | 17.39% |
Stock Price Statistics
The stock price has decreased by -1.83% in the last 52 weeks. The beta is 0.32, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -1.83% |
| 50-Day Moving Average | 421.21 |
| 200-Day Moving Average | 442.83 |
| Relative Strength Index (RSI) | 65.08 |
| Average Volume (20 Days) | 1,405,355 |
Short Selling Information
The latest short interest is 4.01 million, so 1.58% of the outstanding shares have been sold short.
| Short Interest | 4.01M |
| Short Previous Month | 4.13M |
| Short % of Shares Out | 1.58% |
| Short % of Float | 1.58% |
| Short Ratio (days to cover) | 2.92 |
Income Statement
In the last 12 months, VRTX had revenue of $11.72 billion and earned $3.68 billion in profits. Earnings per share was $14.22.
| Revenue | 11.72B |
| Gross Profit | 6.18B |
| Operating Income | 4.54B |
| Pretax Income | 4.45B |
| Net Income | 3.68B |
| EBITDA | 4.71B |
| EBIT | 4.54B |
| Earnings Per Share (EPS) | $14.22 |
Balance Sheet
The company has $6.29 billion in cash and $1.83 billion in debt, giving a net cash position of $10.18 billion or $40.10 per share.
| Cash & Cash Equivalents | 6.29B |
| Total Debt | 1.83B |
| Net Cash | 10.18B |
| Net Cash Per Share | $40.10 |
| Equity (Book Value) | 17.32B |
| Book Value Per Share | 68.20 |
| Working Capital | 6.09B |
Cash Flow
In the last 12 months, operating cash flow was $3.72 billion and capital expenditures -$380.80 million, giving a free cash flow of $3.34 billion.
| Operating Cash Flow | 3.72B |
| Capital Expenditures | -380.80M |
| Free Cash Flow | 3.34B |
| FCF Per Share | $13.15 |
Margins
Gross margin is 52.72%, with operating and profit margins of 38.70% and 31.35%.
| Gross Margin | 52.72% |
| Operating Margin | 38.70% |
| Pretax Margin | 37.95% |
| Profit Margin | 31.35% |
| EBITDA Margin | 40.19% |
| EBIT Margin | 38.70% |
| FCF Margin | 28.47% |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.11% |
| Shareholder Yield | -0.11% |
| Earnings Yield | 3.18% |
| FCF Yield | 2.89% |
Analyst Forecast
The average price target for VRTX is $494.65, which is 8.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $494.65 |
| Price Target Difference | 8.60% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (5Y) | 9.62% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 11.3 and a Piotroski F-Score of 5.
| Altman Z-Score | 11.3 |
| Piotroski F-Score | 5 |